Digital health and pharma – adapting to the post-coronavirus paradigmThe need for digital transformation and a response model for coronavirus were among the topics discussed in a Share XDigital health and pharma – adapting to the post-coronavirus paradigmhttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/digital-health-and-pharma-adapting-to-the-post-coronavirus-paradigm/
Deep Dive: Market Access – Breaking BarriersIn this issue of Deep Dive we look at the changing landscape for pharma market access and start Share XDeep Dive: Market Access – Breaking Barriershttps://pharmaphorum.com/views-analysis-market-access/deep-dive-market-access/
6 ways to digitise your business at paceAs the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact? For decades, I have Share X6 ways to digitise your business at pacehttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/6-ways-to-digitise-your-business-at-pace/
Coronavirus pharma news roundup 15/5/20This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs Share XCoronavirus pharma news roundup 15/5/20https://pharmaphorum.com/r-d/views-analysis-r-d/coronavirus-pharma-news-roundup-15-5-20/
What COVID-19 means for generics companiesGenerics companies have found themselves at the forefront of fighting COVID-19 – but it has required rapid change Share XWhat COVID-19 means for generics companieshttps://pharmaphorum.com/views-analysis-market-access/what-covid-19-means-for-generics-companies/
Coronavirus pharma news roundup – 1/5/2020This week saw several pharma companies reveal how the coronavirus pandemic has affected their sales. Meanwhile, there were Share XCoronavirus pharma news roundup – 1/5/2020https://pharmaphorum.com/views-analysis-market-access/coronavirus-pharma-news-roundup-1-5-2020/
Daiichi Sankyo: pharma needs to become NHS ‘experts’If pharma wants to help the NHS improve outcomes, it needs to do so through a true partnership Share XDaiichi Sankyo: pharma needs to become NHS ‘experts’https://pharmaphorum.com/views-analysis-market-access/daiichi-sankyo-pharma-needs-to-become-nhs-experts/
Coronavirus vaccine: how pharma is picking up the paceThe world is waiting with bated breath for a coronavirus vaccine, which has become one of the most Share XCoronavirus vaccine: how pharma is picking up the pacehttps://pharmaphorum.com/views-analysis-market-access/coronavirus-vaccine-how-pharma-is-picking-up-the-pace/
What can Linux and Mozilla teach ICER about how to do drug value assessments?The Institute for Clinical and Economic Review (ICER) measures the value of new drugs and health technologies, but Share XWhat can Linux and Mozilla teach ICER about how to do drug value assessments?https://pharmaphorum.com/views-analysis-market-access/what-can-linux-and-mozilla-teach-icer-about-how-to-do-drug-value-assessments/
